Organoids by Southwest (OXSW) OXSW, the U.S. subsidiary of OrganoidScience, is dedicated to advancing organoid-based pipeline development.
Based in Texas, our team leverages advanced organoid platforms to identify, validate, and accelerate next-generation therapies.
With a strong foundation in innovation and collaboration, OXSW is committed to shaping the future of biomedical research and therapeutic development. Therapeutic Developer  |